Manual of Nerve Conduction Velocity and Clinical Neurophysiology, 3rd Ed.
暂无分享,去创建一个
[1] J. Weber,et al. A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations , 2011, Genetics in Medicine.
[2] Amber N. Stratman,et al. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. , 2011, The Journal of clinical investigation.
[3] Hugues Duffau,et al. Magnetic Resonance Imaging Evaluation of Cerebral Cavernous Malformations With Susceptibility-Weighted Imaging , 2011, Neurosurgery.
[4] W. Min,et al. Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology , 2011, Proceedings of the National Academy of Sciences.
[5] R. Kucherlapati,et al. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. , 2011, Human molecular genetics.
[6] Dean Y. Li,et al. Evaluating strategies for the treatment of cerebral cavernous malformations. , 2010, Stroke.
[7] R. Shenkar,et al. Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. , 2010, Neurosurgical focus.
[8] I. Awad,et al. Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review. , 2010, Neurosurgical focus.
[9] R. Shenkar,et al. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity , 2010, The Journal of experimental medicine.
[10] L. Morrison,et al. Familial versus Sporadic Cavernous Malformations: Differences in Developmental Venous Anomaly Association and Lesion Phenotype , 2010, American Journal of Neuroradiology.
[11] E. Golanov,et al. Biology of Vascular Malformations of the Brain , 2009, Stroke.
[12] J. Gault,et al. CEREBRAL CAVERNOUS MALFORMATIONS: SOMATIC MUTATIONS IN VASCULAR ENDOTHELIAL CELLS , 2009, Neurosurgery.
[13] R. Shenkar,et al. Immune response in human cerebral cavernous malformations. , 2009, Stroke.
[14] G. Steinberg,et al. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. , 2009, Human molecular genetics.
[15] C. Patterson. Torturing a blood vessel. , 2009, Nature medicine.
[16] Christopher A. Jones,et al. The Cerebral Cavernous Malformation signaling pathway promotes vascular integrity via Rho GTPases , 2009, Nature Medicine.
[17] U. Felbor,et al. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells , 2008, Human molecular genetics.
[18] R. Shenkar,et al. ADVANCED MAGNETIC RESONANCE IMAGING OF CEREBRAL CAVERNOUS MALFORMATIONS: PART II. IMAGING OF LESIONS IN MURINE MODELS , 2008, Neurosurgery.
[19] E. Gasparetto,et al. Susceptibility-Weighted Imaging for the Evaluation of Patients with Familial Cerebral Cavernous Malformations: A Comparison with T2-Weighted Fast Spin-Echo and Gradient-Echo Sequences , 2008, American Journal of Neuroradiology.
[20] R. Shenkar,et al. Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. , 2007, Journal of neurosurgery.
[21] J. Gault,et al. Biallelic Somatic and Germ Line CCM1 Truncating Mutations in a Cerebral Cavernous Malformation Lesion , 2005, Stroke.
[22] Issam A Awad,et al. Differential Gene Expression in Human Cerebrovascular Malformations , 2003, Neurosurgery.
[23] M. Preul,et al. Cerebral cavernous malformations : from genes to proteins to disease Clinical article , 2011 .